Treatment Outcomes and Toxicities for Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab

被引：0
|
作者：
Pakeerathan, Veenaa [1 ]
Babu, Hari [1 ]
Andelkovic, Vladimir [1 ]
机构：
[1] Princess Alexandra Hosp, Woolloongabba, Qld, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [21] Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab
    Brown, Timothy J.
    Gimotty, Phyllis A.
    Mamtani, Ronac
    Karasic, Thomas B.
    Yang, Yu-Xiao
    JCO CLINICAL CANCER INFORMATICS, 2024, 8
  • [22] Impact of coronavirus disease 2019 on patients with unresectable hepatocellular carcinoma treated with atezolizumab/bevacizumab
    Sang, Y. B.
    Lee, C. R.
    Kim, S-G.
    Lee, B.
    Kim, C.
    Chon, H. J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1549 - S1550
  • [23] Long-term survival outcomes of atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma.
    Chen, Ching-Tso
    Feng, Yin-Hsun
    Yen, Chia-Jui
    Chen, San-Chi
    Hsu, Chih-Hung
    Shao, Yu-Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [24] Atezolizumab and Bevacizumab in Hepatocellular Carcinoma REPLY
    Finn, Richard S.
    Cheng, Ann-Lii
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07): : 695 - 695
  • [25] Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
    Al Zahrani, Ali
    Alfakeeh, Ali
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [26] Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
    Ali AL Zahrani
    Ali Alfakeeh
    Journal of Medical Case Reports, 15
  • [27] Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma
    Brackenier, Cedric
    Kinget, Lisa
    Cappuyns, Sarah
    Verslype, Chris
    Beuselinck, Benoit
    Dekervel, Jeroen
    CANCERS, 2023, 15 (02)
  • [28] Serial Changes of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
    Murata, Yosuke
    Nosaka, Takuto
    Akazawa, Yu
    Tanaka, Tomoko
    Takahashi, Kazuto
    Naito, Tatsushi
    Matsuda, Hidetaka
    Ohtani, Masahiro
    Nakamoto, Yasunari
    CANCERS, 2024, 16 (13)
  • [29] Impact of radiological response and pattern of progression in patients with hepatocellular carcinoma treated by atezolizumab- bevacizumab
    Campani, Claudia
    Vallot, Ariane
    Ghannouchi, Haroun
    Allaire, Manon
    Evain, Manon
    Sultanik, Philippe
    Sidali, Sabrina
    Blaise, Lorraine
    Thabut, Dominique
    Nahon, Pierre
    Seror, Olivier
    Ganne-Carrie, Nathalie
    Nault, Jean-Charles
    Wagner, Mathilde
    Sutter, Olivier
    HEPATOLOGY, 2024, 79 (01) : 49 - 60
  • [30] Therapy with Atezolizumab and Bevacizumab prolongs Life of Patients with hepatocellular Carcinoma
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (09):
12345